Diabetes, glycemic control & vascular prevention
Prof John Betteridge, London, reviews new and older diabetes medications and their impact on glycemic control, vascular prevention and Beta cell function, with a particular focus on TZD's
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.
Share this page with your colleagues and friends: